Citron Kinase Is a Cell Cycle-dependent, Nuclear Protein Required for G 2 /M Transition of Hepatocytes by Liu, Huifei et al.
Citron Kinase Is a Cell Cycle-dependent, Nuclear Protein
Required for G2/M Transition of Hepatocytes*
Received for publication, October 10, 2002
Published, JBC Papers in Press, October 30, 2002, DOI 10.1074/jbc.M210391200
Huifei Liu‡, Ferdinando Di Cunto§, Sara Imarisio§, and Lola M. Reid‡¶
From the ‡Department of Cell and Molecular Physiology and the ¶Program in Molecular Biology and Biotechnology,
University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 and the §Department of Genetics,
Biology, and Biochemistry, University of Torino, 10126 Torino, Italy
Citron Kinase (Citron-K) is a cell cycle-dependent pro-
tein regulating the G2/M transition in hepatocytes. Syn-
chronization studies demonstrated that expression of
the Citron-K protein starts at the late S and/or the early
G2 phase after that of cyclin B1. Expression of Citron-K
is developmentally regulated. Levels of Citron-K mRNA
and protein are highest in embryonic liver and gradu-
ally decrease after birth. Citron-K exists in interphase
nuclei and begins to disperse into the cytoplasm at
prophase. It concentrates at the cleavage furrow and
midbody during anaphase, telophase, and cytokinesis,
implicating a role in the control of cytokinesis. How-
ever, studies with knockouts show that Citron-K is not
essential for cytokinesis in hepatocytes. Instead, loss of
Citron-K causes a significant increase of G2 tetraploid
nuclei in one-week-old rat and mouse liver. In addition,
Citron-K deficiency triggers apoptosis in a small subset
of embryonic liver cells. In summary, our data demon-
strate that Citron-K has a distinct cell cycle-dependent
expression pattern and cellular localization as a down-
stream target of Rho-GTPase and functions in the con-
trol of G2/M transition in the hepatocyte cell cycle.
The small GTPase Rho is required for cytokinesis as a reg-
ulator of the actomyosin contractile ring. Immunofluorescence
showed that RhoA accumulates at the cleavage furrow during
cytokinesis in Swiss 3T3 cells and HeLa cells (1, 2). Inactiva-
tion of Rho blocked cytokinesis as demonstrated in several
experimental systems including Drosophila embryos, Xenopus
embryos, mammalian cells, etc. (3–9). RhoA is also critical for
cytokinesis in hepatocytes. Overexpression of the dominant
negative mouse Ect2, a guanine nucleotide exchange factor
(GEF) that activates RhoA, caused cytokinesis failure and the
formation of binucleated cells in cultured mouse hepatocytes
(10).
Rho regulates cytokinesis through its downstream targets.
The Rho-associated kinases ROCK1 I and II and Citron kinase
(Citron-K) bind to Rho-GTP and have been shown to be in-
volved in the regulation of cytokinesis (2, 11–15). ROCKs and
Citron-K are serine/threonine kinases, and they probably reg-
ulate cytokinesis by phosphorylating downstream targets.
ROCKs activate the regulatory myosin light chain (RMLC)
directly by phosphorylating its Ser-19 and indirectly by inhib-
iting myosin phosphatases (12). Citron-K also phosphorylates
RMLC at Ser-19 and Thr-18, but it does not phosphorylate
myosin phosphatases (16).
The gene encoding Citron kinase has two major transcripts,
the full-length Citron-K and a form of Citron that does not
contain the kinase domain (2, 11). Citron is highly expressed in
differentiated neuronal cells (17, 18). In contrast, the expres-
sion of Citron-K mRNA is limited to the proliferating neuro-
blasts, as revealed by in situ hybridization (15). Citron-K
mRNA is detected by Northern blots in adult murine tissues
including brain, kidney, spleen, thymus, skin, lung, and at very
high levels in testis, but it is not detected in liver, heart, and
skeletal muscle (11). Considering its strong expression in
highly proliferative tissues such as testis or embryonic neuro-
nal cells, it is possible that the expression of Citron-K is cell
cycle-dependent rather than tissue-specific. Therefore, the ab-
sence of Citron-K in adult mouse liver could be a consequence
of the quiescent state of the tissue.
The major function of Citron-K is the control of cytokinesis.
Citron-K localizes to the cleavage furrow and midbody in an-
aphase and telophase in HeLa cells (2, 9). Overexpression of
truncated or kinase-dead constructs of Citron-K induces forma-
tion of binucleated HeLa cells (2). The requirement of Citron-K
for cell division is cell type-specific as revealed by examining
the knockout animals. Loss of Citron-K causes failure of cyto-
kinesis and therefore triggers apoptosis in the male germ cells
and a specific population of neuroblasts (15, 19, 20). Whether
Citron-K is involved in the control of hepatocyte cell cycle and
cytokinesis is not clear.
MATERIALS AND METHODS
Reagents—All chemicals were purchased from Sigma except where
otherwise indicated.
Animals—Male adult Fisher 344 rats (2 months old) and pregnant
Fisher 344 rats were purchased from the Charles River Breeding Lab-
oratories (Raleigh, NC). One pair of heterozygous Wistar Kyoto rats
with a mutation at the Citron-K gene was a gift from Dr. Lo Turco,
University of Connecticut, Storrs, CT. They were bred to generate the
Flathead (FH) rats, the heterozygous rats, and the homozygous wild
type (WT) rats. The autosomal recessive mutant FH rat is a spontane-
ous Citron-K knockout. It was named because of an easily recognized
phenotype, a flattened skull of the neonate (21). The mutation was
confirmed to be a single base deletion in the exon 1 of the Citron gene,
resulting in an early stop codon, and no Citron-K protein is synthesized
(20, 21). Genotypes of the littermates were determined by PCR with
genomic DNA followed by restriction enzyme cutting. A fragment of
exon 1 containing the mutation site was amplified by PCR followed by
BanII (Promega, Madison, WI) cutting of the PCR products. The wild
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type gene has a BanII cutting site lost in the mutant. The primers to
exon 1 of the Citron-K gene in rat were based on the sequence of mouse
exon 1 and were 5GAGATGTTGAAGTTCAAGTA-3 and 5CCTGGAA-
GAAGAGATTTAGC-3 (20). Phenotypes of FH rats are very similar to
those observed in the Citron-K / mice with minor differences. Fail-
ure of cytokinesis causes the formation of binucleated neuronal cells.
Massive apoptosis is detected in the developing central nervous system,
which leads to the small brain size at birth (40% of normal) (22). FH
rats begin to have seizures around postnatal day 7 and die in the first
month (23). All animal studies were approved by the Institutional
Animal Care and Use Committee of the University of North Carolina at
Chapel Hill. Experiments have been conducted in accordance with the
Guide for the Care and Use of Laboratory Animals published by the
National Institutes of Health.
Liver Perfusion—Single cell suspensions of hepatocytes were pre-
pared with a modified two-step collagenase perfusion method (24). Cell
viability was 90% as measured by trypan blue exclusion.
Primary Cultures of Rat Hepatocytes—Freshly isolated hepatocytes
were seeded onto type I collagen (5–10 g/cm2)-coated tissue culture
plates or coverslips at a density of 15,000 cells/cm2 to 20,000 cells/cm2
for maximal cell proliferation (25). Cells were seeded in RPMI 1640
(Invitrogen) supplemented with 10% fetal bovine serum (Hyclone,
Logan, UT) and 5 g/ml insulin with 100 g/ml streptomycin and 100
units/ml penicillin for 4 h. The culture was then changed to a serum-
free medium; RPMI 1640 was supplemented with 10 g/ml iron-satu-
rated transferrin, 100 nM dexamethasone, 5 g/ml insulin, 10 ng/ml
epidermal growth factor (EGF), 1  107 M copper (CuSO4), 5  10
11
M zinc (ZnSO47H2O), 3  10
10 M selenium (NaSeO3), 100 g/ml strep-
tomycin, and 100 unit/ml penicillin. Both epidermal growth factor and
insulin are hepatic mitogens and provide an additive stimulus for cell
proliferation in culture.
Binucleation Ratio of Hepatocytes—Single cell suspensions of rat
hepatocytes were fixed with 3.7% formaldehyde in PBS for 10 min and
then stained with Hoechst 33342 (5 g/ml in PBS and 0.1% Triton
X-100, Molecular Probes, Eugene, OR). Cells were then checked under
a fluorescence microscope. At least 2000 cells were counted for each
sample, and the binucleation ratio of hepatocytes was calculated as the
percentage of binucleated cells per total number of hepatocytes.
Nuclei Isolation and Flow Cytometric Analysis—Nuclei of rat hepa-
tocytes were prepared by a modified trypsin-detergent method (26). A
total of 20,000 events was collected for each sample with a FACScan
(BD Biosciences). Quantitative analysis of cell cycle parameters was
performed using the WinMDI program.
RT-PCR—A human fetal cDNA panel was purchased from Clontech
and used as the template for PCR. Total RNA from liver samples were
isolated using the RNeasy Mini kit (Qiagen, Valencia, CA). The cDNA
was synthesized from 5 g of total RNA using the SuperScriptTM first
strand synthesis system for RT-PCR (Invitrogen). To detect the specific
signal for Citron-K, the forward primer was designed to locate within
the kinase domain, and the reverse primer would be in the non-kinase
domain of the molecule. The forward primer was designed according to
the sequence of the rat Citron kinase domain nucleotides 883–906, i.e.
5-TGGACTGTGACTGGTGGTCTGTCG-3, whereas the reverse
primer corresponds to rat Citron 1154–1177, i.e. 5-TGGCCTCTGTG-
CTGGCTTTTACAG-3. The primers amplify a 1.1-kb PCR fragment
according to the sequence information of mouse Citron-K. These two
primers are separated by at least one intron. Thus, a positive PCR
signal with the right length should reflect the existence of the Citron-K
mRNA. The PCR product was purified and sequenced to confirm that it
is an amplified fragment of rat Citron-K cDNA. Semi-quantitation of
PCR products is performed according to the method of Relative RT-PCR
(Ambion, Austin, TX) by using -actin as an internal standard with
Ambion’s QuantumRNATM -actin internal standards kit.
In Situ Hybridization—In situ hybridization was performed as de-
scribed (15), with antisense RNA probes transcribed from plasmids
containing fragments of Citron-K (nucleotides 911–2056) (11).
Hep3B Cell Culture and Transfection—Hep3B cells were cultured on
22-mm2 coverslips in RPMI 1640 supplemented with 10% fetal bovine
serum, 100 g/ml streptomycin, and 100 units/ml penicillin. Transfec-
tion was performed using FuGENE 6 transfection reagent (Roche). The
cDNA of mouse Citron-K was cloned in-frame with an N-terminal FLAG
tag in the pcDNA3 expression vector (Invitrogen) (11). Cells were cul-
tured for 24–48 h after transfection to allow gene expression.
Immunofluorescence—Rat hepatocytes and Hep3B cells cultured on
coverslips were fixed in methanol/acetone (1:1) for 5 min, and incubated
with blocking buffer (phosphate-buffered saline, 2% goat serum, 0.1%
Triton X-100) for 10 min. Primary antibodies were diluted with blocking
buffer and used as follows: mAb mouse anti--tubulin 1:100 (Oncogene,
Cambridge, MA); mouse anti-FLAG 1:200 (M2, Sigma); mouse anti-
phospho-histone H3 (Ser-10) 1:100 (Cell Signaling, Beverly, MA); and a
polyclonal rabbit anti-Citron antibody at 1:4000 (prepared by immuni-
zation of rabbits with a purified fragment of mouse Citron-K amino
acids 454–637) (15). The secondary antibodies Alexa 488 conjugated
goat anti-mouse IgG and Alexa 594 conjugated goat-anti-rabbit IgG
(Molecular Probes) were diluted 1:500 with blocking buffer and incu-
bated with the fixed cells for 1 h. Cells were then stained with Hoechst
33342 (Molecular Probes) to visualize the DNA. The stained cells were
examined with an Olympus IX70 microscope (Olympus, Melville, NY) or
a Leica confocal microscope.
Immunohistochemistry—Embryos were fixed by immersion in 4%
paraformaldehyde in PBS for over 12 h, embedded in paraffin, and
sectioned at 5 m. Sections containing liver were stained with hema-
toxilin-eosin. Activated Caspase-3 was detected with an affinity-puri-
fied rabbit polyclonal antiserum (dilution 1:1000), which recognizes the
p17 subunit of cleaved caspase-3 (kindly provided by Dr. A. Nelsbach,
New England Biolabs, Beverly, MA).
Immunoprecipitation and/or Western Blotting—Immunoprecipita-
tion and Western blotting were performed as described previously (11).
Liver tissue samples were homogenized in a high stringency buffer (120
mM NaCl, 50 mM Tris-HCl, pH 8.0, 0.5% Nonidet P-40) with supple-
mented protease inhibitors (100 g/ml phenylmethylsulfonyl fluoride,
45 g/ml aprotinin, 1 mM sodium orthovanadate, 10 g/ml leupeptin, 1
mM EDTA, 2 g/ml antipain, and 1 g/ml pepstatin A). Immunoprecipi-
tation was performed with the rabbit polyclonal anti-Citron antibody
(15) at a dilution of 1:2000. Cultured Hep3B cells and primary cultures
of hepatocytes were harvested in radioimmune precipitation (RIPA)
buffer (150 mM NaCl, 50 mM Tris-HCl, pH8.0, with 1% Nonidet P-40,
0.5% sodium deoxycholate, 0.1% SDS) supplemented with the same set
of protease inhibitors. Protein lysates or precipitates from immunopre-
cipitation were run on SDS-PAGE gels and transferred to an Immobilon
polyvinylidene difluoride membrane (Millipore, Bedford, MA). Citron
and Citron-K were detected with the same anti-Citron antibody at
1:4000. Other antibodies used were monoclonal antibody against cyclin
B1, 1:200 (NeoMarker, Fremont, CA), and proliferating cell nuclear
antigen (PCNA), 1:10,000 (Sigma). The secondary antibodies were
horseradish peroxidase-conjugated goat anti-mouse (Amersham Bio-
sciences) and goat anti-rabbit (Jackson Laboratories, West Grove, PA)
used at a dilution of 1:10,000 and 1:40,000, respectively. The signal was
detected with an ECL plus kit (Amersham Biosciences) according to the
manufacturer’s instructions. The results shown are representative of at
least three independent experiments. Densitometric analysis of Cit-
ron-K protein levels during development was quantified with the soft-
ware Scion Image (Scion Corporation, Frederick, MD). Relative expres-
sion levels were determined by dividing the mean densitometric value
of each stage by that found in the livers of first postnatal week animals.
Partial Hepatectomy—Two-thirds partial hepatectomy (PH) was per-
formed on 2-month-old male F344 rats as described previously (27).
Liver samples removed during surgery were saved as time 0 quiescence
controls. Animals were euthanized by CO2 asphyxiation at the following
hourly intervals after PH: 20, 22, 24, 26, 28, and 30 h. Portions of livers
were snap frozen in liquid nitrogen and stored at 80 °C for protein
extraction. A sham operation, including laparotomy and mobilization of
liver without tissue removal, was performed as a control.
Statistical Analysis—Significance of differences between FH rats
and WT control was assessed by the Student’s t test. p  0.05 means
significant difference.
RESULTS
Expression of Citron Kinase Is Not Tissue-specific but Cell
Cycle-dependent—Expression of Citron-K has been considered
tissue-specific, because Citron-K mRNA is not detected in adult
mouse liver, heart, and skeletal muscle by Northern blots (11).
In situ hybridization studies have shown that Citron-K mRNA
was detected only in proliferating but not postmitotic neuronal
cells (15), a phenomenon that could occur in other tissues. If so,
the negative signal in adult mouse liver, heart, and skeletal
muscles could be a result of their quiescent states. A positive
signal of Citron-K should be detected in these tissues if under-
going proliferation. To address this question, Citron-K expres-
sion in proliferating cells was evaluated. RT-PCR detected
Citron-K mRNA in human fetal heart, liver, spleen, kidney,
thymus, skeletal muscle, and lung (Fig. 1A). In situ hybridiza-
tion detected a positive signal of Citron-K mRNA in mouse fetal
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liver (Fig. 1B). Citron-K is detected by Western blots in cul-
tured Hep3B cells, embryonic day 15 (E15) rat liver, and cul-
tured proliferating rat hepatocytes but not in quiescent adult
rat hepatocytes (Fig. 1, C and D). These results strongly argue
that Citron-K expression is cell cycle-dependent rather than
tissue-specific.
The expression pattern of Citron-K was further character-
ized in regenerating liver after two-thirds PH because the first
round of DNA synthesis by hepatocytes is naturally synchro-
nized, providing a convenient model for studying the cell cycle
expression pattern of proteins. Rat hepatocytes reach first peak
of DNA synthesis at 24 h after PH as revealed by BrdUrd
labeling and PCNA expression (27–30). Thus, we followed the
protein expression 24 h after surgery. Previous studies have
demonstrated that cell proliferation induced by PH is predom-
inantly non-binucleating (31, 32). Thus, the expression of Cit-
ron-K in the regenerative liver after PH will provide important
information as to the relationship between Citron-K and liver
cell cytokinesis.
The expression of two well studied cell cycle markers was
examined to define stages of the cell cycle. PCNA starts to
appear at the end of G1, peaks in S, and declines at the G2/M
phases (33, 34). It has been shown that the protein level of
PCNA parallels DNA synthesis as revealed by BrdUrd or
[3H]thymidine incorporation in the regenerating liver after PH
(27, 30). Cyclin B1 is a critical regulator of mitosis. Expression
of cyclin B1 starts at late S phase and accumulates until met-
aphase (35). After that, it is degraded quickly by a ubiquitin-
dependent mechanism.
The protein level of Citron-K was detected using immuno-
precipitation followed by Western blotting. The protein level of
PCNA and cyclin B1 were analyzed using Western blots di-
rectly. PCNA protein level reached its first peak at 24 h after
PH, a finding that is consistent with the literature. Citron-K
was detected as early as 26 h after PH when cyclin B1 reached
its first peak (Fig. 2B). These protein expression changes were
not observed in the sham-control animals (data not shown).
The data presented here demonstrate that expression of
Citron-K is cell cycle-dependent, not tissue specific. Its expres-
sion starts after that of cyclin B1 in the mitotic cell cycle,
probably at late S and/or early G2 phase.
Cellular Localization of Citron Kinase—Comparing the im-
munofluorescence signals from WT and FH hepatocytes per-
mitted the identification of the specific signal derived from
Citron-K. An evenly distributed positive nuclear signal was
detected in a small subset of interphase nuclei in WT hepato-
cytes but not FH cells (Fig. 3A). A positive nuclear signal was
also detected in cultured Hep3B cells, and this was further
confirmed by XZ scanning with a confocal microscope (Fig. 4A).
An examination of transfected FLAG-tagged Citron-K in
Hep3B cells showed that overexpressed exogeneous Citron-K
presented itself as puncta in interphase cells, and some puncta
were localized in the nuclei as confirmed by confocal micros-
copy (Fig. 4B). Double staining with an antibody against the
phosphorylated histone H3 at serine 10 allowed the recognition
of mitotic cells. Citron-K began to disperse into cytoplasm at
prophase (Fig. 5, A and B) and was distributed to the whole
cytosol during prometaphase (Fig. 5C), metaphase (Fig. 3B),
and early anaphase (Fig. 3A). It moved to the cleavage furrow
during anaphase (Figs. 3B and 6A) and concentrated at mid-
body during telophase and cytokinesis (Fig. 6B), which is con-
sistent with previous reports on HeLa cells (2, 9). A punctate
signal was detected in some interphase and mitotic cells (Figs.
3B and 6, C and D). Double staining with anti--tubulin anti-
body showed that the intracellular puncta resembled the signal
from the midbody residue after cytokinesis (Fig. 6, C and D).
The intracellular puncta could be detected in any part of the
cytosol, including cleavage furrow. In most cases, only 1–3
puncta existed in a single hepatocyte.
Expression of Citron Kinase Declines Gradually during De-
velopment—The mRNA level of Citron-K was detected with
RT-PCR and further quantified with -actin serving as an
internal standard. The mRNA level of Citron-K was detected in
embryonic day 14 (E14) rat livers and increased to its highest
level in E15 and E16 rat livers. Its expression gradually de-
clined after birth and was beneath the detection limit of RT-
PCR after the third postnatal week (Fig. 7A).
Protein expression of Citron-K showed a similar pattern to
that of its mRNA. The level of Citron-K protein was highest in
E15 rat liver; it decreased after birth and stayed stable for the
first week, then it decreased again and stayed at that level
until weaning, when a third decrease happened. After that,
FIG. 1. Expression of Citron kinase is not tissue-specific but
cell cycle-dependent. A, RT-PCR showed expression of Citron-K
mRNA in human fetal tissues. Lane 1, thymus; lane 2, kidney; lane 3,
skeletal muscle; lane 4, lung; lane 5, spleen; lane 6, heart; and lane 7,
liver. B, in situ hybridization (ISH) detected a positive signal of Cit-
ron-K mRNA in embryonic mouse liver. H, heart; L, liver; H&E, hema-
toxilin-eosin. C, Western blots detected Citron-K protein expression in
embryonic day 15 rat liver. Lane 1, adult rat cerebellum; lane 2, em-
bryonic day 15 rat liver. D, Western blots detected Citron-K protein
expression in the cultured Hep3B cell line and in cultured proliferating
rat hepatocytes. Lane 1, adult rat cerebellum; lane 2, cultured Hep3B
cell line; lane 3, freshly isolated hepatocytes from 2-month-old rat; lane
4, hepatocytes in culture for 72 h under the stimulation of insulin and
epidermal growth factor.
FIG. 2. Expression of PCNA, cyclin B1, and Citron-K proteins
in regenerating liver after two-thirds partial hepatectomy. Ex-
pression of cyclin B1 and PCNA protein was analyzed by Western
blotting. Total protein (50 g) was loaded from each samples. Immuno-
precipitation followed by Western blots was used to detect Citron-K.
Total protein (3 mg) of each sample was used to pull down Citron-K.
Liver tissue removed during the surgery was saved as the time zero (T0)
control. T20–30 represented 20–30 h after PH. Shown is a represent-
ative result of three independent experiments.
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Citron-K was no longer detected by Western blots (Fig. 7B). In
addition, expression of Citron was also detected in rat liver and
mirrored that of Citron-K with a gradually decreasing pattern
during the first 4 weeks of postnatal life. A very low and
constant level of both Citron and Citron-K protein was detected
in rat livers at weeks 4 and 5 with immunoprecipitation fol-
lowed by Western blots (Fig. 7C). Densitometric analyses of the
Western blots indicated that Citron-K protein levels in E15 rat
livers were as much as 8.25-fold higher than those observed in
the livers in the first postnatal week (Fig. 7D). In addition, by
the time of weaning Citron-K had declined to a level that was
only 5% of that in the first postnatal week. Finally, the ratio of
Citron-K versus Citron decreased from four at E15 to one after
weaning. In summary, both mRNA and protein expression of
Citron-K decrease gradually after birth, reaching the lowest
level after weaning.
Citron-K Knockout Mice and Rats (Flathead Rats)—The
relevance of Citron-K to the cell cycle and cytokinesis control
in hepatocytes was examined by comparing the nuclear pat-
tern and ploidy level of hepatocytes in FH rats with that in
WT littermates. Based on the developmental expression pat-
tern of Citron-K, neonates were examined in their first post-
natal week when Citron-K is still expressed at a relatively
high level. This stage also provides a better match of the body
weight of the animals because FH rats grow slower than their
littermates, and the differences in body weight and body size
become more apparent after 1 week. Finally, interference
from the natural binucleating process of hepatocytes is re-
duced to a minimal level at this age of the animals. Western
blotting confirmed that no Citron-K was detected in either
the freshly isolated or the cultured proliferating hepatocytes
from FH rats (Fig. 8A). Isolated hepatocytes were cultured
and checked under phase contrast microscope after 24 h.
Cells from WT and FH rats presented a similar morphology
in culture (data not shown). A low percentage of binucleated
hepatocytes do exist in both WT and FH animals but with no
FIG. 3. Cellular localization of Cit-
ron-K. The merged image is a double
staining of Citron-K (green) and DNA
(red). A, cultured rat hepatocytes. B, cul-
tured Hep3B cells.
FIG. 4. Confocal microscopy to confirm the nuclear localiza-
tion of Citron-K. A, endogenous Citron-K localizes in a small subset of
interphase Hep3B cells. Green, Citron-K; red, DNA. B, exogenous Cit-
ron-K exists in the nuclei of Hep3B cells transfected with FLAG-Cit-
ron-K plasmid. Green, FLAG-Citron-K; red, DNA.
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significant difference (2.8  0.35% for FH and 2.6  0.53% for
WT, n  4, p  0.05) (Fig. 8B). These results suggest that
Citron-K is not essential to the cytokinesis of rat hepatocytes
and that some functionally redundant molecules exist in
these cells. Flow cytometric analysis of hepatocyte nuclei
from one-week-old rats revealed a significant 50% increase of
the G2 tetraploid nuclei in FH rat livers over controls (5.0 
0.22% for FH versus 3.3  0.28% for WT, n  5, p  0.05) (Fig.
8C). There were no significant differences among the diploid
G0/G1 nuclei percentages between FH and WT animals (WT
93.3  0.44% versus FH 91.6  0.53%, n  5, p  0.05) and
those in S phase (WT 3.4  0.20% versus FH 3.4  0.34%, n 
5, p  0.05). Identical results have been obtained with Cit-
ron-K / mice (data not shown). These data indicate that
Citron-K influences the G2/M phase transition of the cell
cycle in hepatocytes. Moreover, increased apoptosis was de-
tected in embryonic livers of the Citron-K / mice. Acti-
vated caspase 3 immunostaining, a marker for apoptotic
cells, was obvious in the liver of E14.5 Citron-K / mice but
not WT animals (Fig. 8D), suggesting that Citron-K is essen-
tial to some embryonic liver cells.
The structural and functional similarity between ROCKs
and Citron-K make ROCKs the possible candidates to compen-
sate the lost function of Citron-K. Protein levels of ROCKs in
FH rats and the inhibition of ROCK function in Citron-K
knockout cells might reveal whether the dispensability of Cit-
ron-K is due to the up-regulation and/or existence of ROCKs.
Western blotting detected similar protein levels of ROCK I and
ROCK II in both freshly isolated and cultured hepatocytes from
WT and FH rats (Fig. 8E). Thus, the expression of ROCKs was
not up-regulated in the Citron-K deficient situation. The re-
quirement of Citron-K and ROCKs for hepatocyte cytokinesis
was further investigated with the application of the specific
inhibitor of ROCKs, Y-27632, to the primary culture of isolated
hepatocytes from both WT and FH rats. The efficacy of Y-27632
was confirmed by blocking the formation of stress fibers in NIH
3T3 cells at 10 M after 1 h and after 24 h of treatment (data
not shown). Adding Y-27632 at four different concentrations
(10, 25, 50 and 100 M) to the cultured cells did not show easily
detectable changes in cytokinesis in both WT and FH cells
(data not shown).
DISCUSSION
This study demonstrates that Citron-K is the first known
Rho-GTP downstream target with a cell cycle-dependent ex-
pression pattern and has a nuclear localization at interphase.
In addition to a possible involvement in cytokinesis control, it is
required for the G2/M transition of hepatocytes.
Citron-K Has a Distinct Cell Cycle-dependent Expression
Pattern and Cellular Localization—The expression of Citron-K
is not tissue-specific but cell cycle-dependent. This result ex-
tends the previous observations on the central nervous system,
i.e. that mRNA of Citron-K is detected only in proliferating but
not postmitotic neuronal cells (15). It also explains that the
absence of Citron-K mRNA in adult liver, and presumably also
skeletal muscle and heart, is due to the quiescent state in these
organs. The developmental expression data further confirms
the cell cycle-dependent expression pattern of Citron-K, as it
was shown previously that the percentage of cycling cells is
quickly reduced in rat liver after birth (36). On the other hand,
the decline of both Citron-K mRNA and protein after weaning
is inversely correlated with the postweaning binucleation of
hepatocytes. Considering the function of Citron-K in the con-
trol of cytokinesis, this observation might provide some indirect
evidence to support the long believed hypothesis that acytoki-
nesis is the basis of hepatocyte binucleation.
The small GTPases of the Rho family members are critical
regulators in many important cellular functions. At present,
FIG. 5. Cellular localization of Citron-K in cultured rat hepa-
tocytes during prophase and prometaphase. A, Citron-K began to
move to cytoplasm at early prophase. B, Citron-K localized to both
nucleus and cytosol during prophase, C, Citron-K dispersed to the
whole cytosol during prometaphase. The merged image is a double
staining of Citron-K (green) and phospho-histone H3 (Phospho-H3) at
Ser-10 (red). Bars, 5 m.
FIG. 6. Cellular localization of Citron-K in cultured rat hepa-
tocytes. The merged image is a triple staining of -tubulin (green),
Citron-K (red), and DNA (blue). A, Citron-K localizes to cleavage furrow
during anaphase. B, Citron-K localizes to midbody during telophase
and cytokinesis. C, Citron-K presents itself as puncta in some inter-
phase and mitotic cells. D, Citron-K puncta exist at midbody at the end
of cytokinesis and in some interphase cells.
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Citron-K is the only known downstream target of Rho that
presents a cell cycle-dependent expression pattern, which
makes it extremely possible that Citron-K might act to switch
Rho from its other cellular functions to its role in cytokinesis.
In support of this idea, a reduced RhoA signal at the cleavage
furrow was detected in mitotic neuronal cells isolated from
Flathead rats, suggesting that localization of RhoA to the cleav-
age furrow is partly Citron-K-dependent (20).
The finding of increased G2 nuclei in the liver of the Citron-K
knockouts implies that Citron-K functions in the G2/M transi-
tion, which is consistent with observations on the central nerv-
ous system in Citron-K knockout mice (15). The small differ-
ence in the numbers of G2 nuclei would be more meaningful
considering that there is only a small percentage of cycling
cells, whereas the majority of the diploid nuclei are actually in
the quiescent G0 state.
The immunofluorescence antibody staining shows that Cit-
FIG. 8. Analysis of the liver from Citron-K knockouts. A, Citron-K
protein is not detected in both freshly isolated and cultured hepatocytes of
FH rats by Western blotting. Total protein loaded for each sample was 50
g. B, binucleation ratio of hepatocytes isolated from Citron-K / and
	/	 rats. Binucleated cells were counted, and binucleation percentage
was calculated as 2.8  0.35% for FH and 2.6  0.53% for WT, n  4, p 
0.05. C, flow cytometrical analysis of hepatocyte nuclear ploidy from WT
and FH rats during the first week after birth. There was no significant
difference between the WT and FH group of diploid G0/G1 (WT 93.3 
0.44% versus FH 91.6  0.53%) and S phase (WT 3.4  0.20% versus FH
3.4  0.34%) nuclei, but there is a 50% increase of G2 population (5.0 
0.22% for FH versus 3.3  0.28% for WT) (n  5, *p  0.05 for G2). D,
increased apoptosis in embryonic liver of Citron-K / mice. Sections of
the E14.5 liver of Citron-K 	/	 and / mice were analyzed by anti-
activated caspase-3 immunohistochemistry to detect apoptotic cells. KO,
knockout. Bar, 200 m. Arrow points to activated caspase-3 staining. E,
Protein levels of ROCK I and II in both freshly isolated and cultured
hepatocytes from 1-week old WT and FH rats examined by Western blots.
An equal amount of 50 g of total protein was loaded for each sample.
FIG. 7. Citron kinase expression decreases gradually during
development in rat liver. A, relative RT-PCR confirms the quantita-
tive changes of Citron-K mRNA during rat liver development. Semi-
quantitative analysis of the RT-PCR products was achieved by using
-actin as an internal standard. E14-16, embryonic days 14–16. P1–60,
postnatal days 1–60. B, Citron-K protein level gradually decreased
during development as revealed by Western blots. E15, embryonic day
15; P1–22, postnatal days 1–22. Total protein loaded in E15 samples (50
g) was only half of that after birth (100 g). C, immunoprecipitation
followed by Western blotting to show the low levels of both Citron-K and
Citron-N in the liver from P15-P35 day-old rats. Total protein used for
immunoprecipitation was 6 mg. P15–35, postnatal days 1–35. Shown is
a representative result of three independent experiments. D, densito-
metric analysis to show the relative level of Citron-K protein expression
during development in rat liver. Each stage consisted of 4–10 samples.
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ron-K is a nuclear protein in a small percentage of interphase
cells. Confocal microscopy confirms that both endogenous Cit-
ron-K and some exogenous FLAG-tagged Citron-K proteins
localize in the nuclei. The fact that overexpressed FLAG-tagged
Citron-K exists in the cytosol and the nucleus suggested that
the nuclear import of Citron-K requires a specific condition. By
searching the Prosite data base, a potential bipartite nuclear
targeting sequence has been found in the Citron-K protein (39).
Double staining with the anti-phospho-histone H3 Ser-10 an-
tibody shows that cells at later G2 and prophase have a nuclear
positive signal for Citron-K, which is consistent with our West-
ern blot data on the expression pattern of Citron-K. The nu-
clear localization of Citron-K may provide useful information
for understanding the mechanism of Citron-K in the control of
the G2/M transition. Thus, Citron-K is a downstream target of
Rho with a nuclear localization. Because Rho is a cytoplasmic
protein, the function of Citron-K in the nucleus may not be
Rho-dependent. An interesting note to mention is that mouse
Ect2/Drosophila pebble, an upstream stimulator of Rho, also has
a cell cycle-dependent expression pattern, a nuclear localization
at interphase, and a function in cytokinesis regulation (37).
An additional observation in our study is that Citron-K still
diffuses to the whole cytosol at the beginning of anaphase, right
after the sister chromatids dissociate from each other. Citron-K
then quickly moves to the cortex of the cleavage furrow, a time
point we speculate to be the initiation of cytokinesis. Whether
this transition is a precondition or a consequence of the forma-
tion of the cleavage furrow, it suggests that Citron-K is prob-
ably involved in the earliest step of cytokinesis, even though a
truncated Citron-K construct only interfered with the final
stages of cytokinesis in transfected HeLa cells (2).
In a previous paper it was argued that Citron-K existed as
puncta in interphase cells (9). These punctas dispersed into the
whole cytosol during prometaphase in order to conduct their
function during cytokinesis. We question this interpretation for
several reasons. These punctate signals resemble the midbody
residue after cytokinesis. In most situations, only 1–3 punctas
were observed in a single hepatocyte, whereas a similar num-
ber of puncta were observed in both interphase and mitotic
cells. According to our results, Citron-K is a cell cycle-depend-
ent protein expressed after cyclin B1. However, no obvious
pattern was found between the number and size of the puncta
with the cell cycle progress. In addition, it is hard to believe
that the Citron-K protein that exists in this state could be
functionally active in controlling the G2/M transition. As re-
ported previously, abscission occurred at the intercellular
bridge on one side of the midbody, and the midbody residue was
then left in the other side’s daughter cell after cytokinesis (38).
We would propose that some if not all punctas are more likely
the residue of the midbody left in one daughter cell.
Citron-K Regulates Cytokinesis in Hepatocytes—The impor-
tance of Citron-K in the control of cytokinesis in hepatocytes is
implicated by several observations. Citron-K localizes to the
cleavage furrow and midbody during cytokinesis. The expres-
sion of Citron-K is highly up-regulated in proliferating dividing
hepatocytes both in vivo and in vitro. In contrast, its expression
is down-regulated during the postweaning binucleation of
hepatocytes, a process believed to be caused by acytokinesis.
The knockout studies indicate that Citron-K is not essential for
cytokinesis in postnatal hepatocytes. Several possibilities
should be considered. There might be unidentified functionally
redundant molecules in these cells, considering the importance
of cytokinesis. The control mechanism of cytokinesis could be
different in varied cell types, and Citron-K might regulate a
dispensable step of cytokinesis in hepatocytes. There could be
distinct isoforms of Citron-K that are functional in embryonic
versus adult developmental stages. Thus, the susceptibility to
apoptotic death could be different in embryonic versus postna-
tal cells as observed in the central nervous system and in the
testis (15, 19, 22). The knockout shows only a low penetrance
cytokinesis phenotype due to the elimination of the binucleated
hepatocytes by apoptosis during embryonic stages as suggested
by increased activated caspase-3 staining in the fetal liver of
Citron-K / mice.
ROCKs, the homologues of Citron-K and also the down-
stream targets of Rho-GTP involved in the regulation of cyto-
kinesis, were the most promising functionally redundant alter-
natives. Both Citron-K and ROCKs phosphorylate the RMLC
during cytokinesis (12, 16). However, the absence of Citron-K
did not result in up-regulation of ROCKs in the neural cells (15)
or the liver cells. In the Citron-K-sensitive neuronal cells,
ROCKs do not cover the lost function caused by deficiency of
Citron-K (15). Furthermore, our results show that inhibition of
the kinase activities of ROCKs by its specific inhibitor Y-27632
does not block cytokinesis in cultured Citron-K / hepato-
cytes. This confirms that the lost function of Citron-K is not
compensated by the kinase activity of ROCKs. In addition, even
if RMLC is a substrate of both Citron-K and ROCKs during
cytokinesis, it must be activated by at least one other kinase
such as the myosin light chain kinase in these cells.
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